Tru Niagen Review: Does NR Actually Work?

Tru Niagen occupies an unusual spot in the NAD+ supplement world: it's the rare product whose active ingredient has actually been put through placebo-controlled human trials — including ones using this exact branded material. That alone sets it apart from most of the category, where "clinically studied" usually means a single study on a different compound. So Tru Niagen deserves a serious, evidence-based look. But "more studied than its rivals" is not the same as "proven to do what the marketing implies." This review separates the two: what the trials reliably show (the biomarker), and where the evidence thins out (the benefits you actually care about).

What Tru Niagen is

Tru Niagen is the consumer brand for Niagen, ChromaDex's patented form of nicotinamide riboside (NR) — one of the two leading oral NAD+ precursors (the other being NMN). NR is a vitamin-B3 derivative that your body converts into NAD+, the coenzyme at the center of cellular energy metabolism and DNA-repair signaling. The pitch is straightforward: take NR daily, raise your NAD+, and theoretically support healthy aging, energy, and cellular resilience.

The reason Tru Niagen is worth reviewing on its own terms — rather than lumping it in with the dozens of generic NR and NMN brands — is its research footprint. The Niagen ingredient has been the subject of multiple peer-reviewed human trials, and crucially, a dedicated long-term safety trial. That's a genuine differentiator in a category full of products with no human data at all. For how NR stacks up against NMN head-to-head, see our NMN vs NR trial breakdown.

Does it raise NAD+? Yes — reliably

Start with the strongest claim, because it's the one that holds. NR reliably raises NAD+ in humans. A foundational 2016 study established that NR is uniquely and orally bioavailable in humans, raising blood NAD+ measurably after dosing ¹. A 2018 randomized trial confirmed that chronic NR supplementation is well tolerated and elevates NAD+ in healthy middle-aged and older adults ².

Most relevant to Tru Niagen specifically: a 2019 randomized, double-blind, placebo-controlled trial of NIAGEN (the exact ingredient) in healthy overweight adults found that long-term administration was safe and well tolerated, and that it increased whole-blood NAD+ by roughly 40–50% at the studied doses ³. So the central mechanistic promise — "this raises your NAD+" — is about as well established as anything in the supplement world. If your only question is "will Tru Niagen actually increase my NAD+?", the honest answer is yes, it very likely will.

Does the NAD+ increase translate into benefits? This is where it thins out

Here's the uncomfortable pivot the marketing glides past: raising NAD+ is not the same as improving how you feel, perform, or age — and in trial after trial, the biomarker moves while the outcome doesn't.

The clearest cautionary result comes from muscle. When NR augmented the aged human muscle NAD+ metabolome (and produced anti-inflammatory gene signatures), it did not improve muscle bioenergetics or physical performance ⁴. The fuel gauge rose; the engine output stayed flat. On cognition, the story repeats: a randomized placebo-controlled trial in older adults with mild cognitive impairment raised blood NAD+ about 2.6-fold but left neurocognitive scores unchanged ⁵.

NR does have one concrete, specific functional win. In the NICE randomized trial in patients with peripheral artery disease, six months of NR produced a small but significant improvement in 6-minute walking distance — on the order of +17.6 m between groups, larger among adherent participants ⁶. That's a real, modest benefit, but note what it is: a specific outcome, in a specific patient population, not a general energy-or-longevity boost for healthy users. And a 2025 systematic review and meta-analysis of NR and NMN on skeletal muscle mass and function found no reliable improvement when results were pooled across trials ⁷ — reinforcing that the muscle/strength benefits implied by the marketing aren't dependably there.

Safety: genuinely reassuring

Where Tru Niagen earns real credit is safety. The dedicated NIAGEN trial found long-term administration safe and well tolerated with no significant adverse safety signals ³, and the broader NR literature is consistent: chronic dosing is well tolerated across trials ². NR is sold as a dietary supplement, not an approved drug, so it isn't FDA-approved to treat any condition — but on the narrow question of "is taking it likely to harm me?", the human safety record is one of the better ones in the longevity-supplement space. (As always, anyone pregnant, nursing, on medication, or with a medical condition should check with a clinician first.)

Is Tru Niagen worth it?

Put the pieces together honestly:

• •What you're reliably buying: a well-studied, well-tolerated NR product that will very likely raise your NAD+ by roughly 40–50% ³. The dose transparency and research backing are genuinely above the category average.
• •What you're not reliably buying: proven improvements in energy, cognition, strength, or longevity. The downstream human benefits are modest, mixed, and largely confined to specific populations or specific outcomes ⁴⁵⁷.
• •The price reality: Tru Niagen typically sits at the premium end for an NR supplement. You're paying partly for the research pedigree and quality control — which are real — and partly for benefits that the trials haven't reliably demonstrated.

So the fair verdict is: if you want the most-studied, best-safety-documented NR and you understand you're mainly buying a reliable NAD+ increase — not a proven anti-aging or energy effect — Tru Niagen is a defensible choice. If you're expecting the dramatic benefits the category markets, the evidence will disappoint you, and that's true of every NAD+ precursor, not just this one.

Bottom line

Tru Niagen is the strongest-evidenced NR brand by research footprint, and the part of its pitch that survives scrutiny is the biomarker: it reliably and safely raises NAD+ ~40–50% ³. The part that doesn't fully survive scrutiny is the implied payoff — better energy, cognition, and aging — where human trials show the NAD+ increase often fails to translate into felt or measured benefit ⁴⁵. It's a high-quality product for a goal (raising NAD+) whose downstream value remains modest and unproven. To compare it against NMN and other precursors on evidence and price, see our best NAD+ supplements ranking and best NMN supplements ranking; for the full context on what raising NAD+ can and can't do, start with our NAD+ therapy evidence pillar and the NAD+ rankings hub.